PracticeTestVault review illustration for radiopharmaceutical preparation on NMTCB Nuclear Medicine Technology

PracticeTestVault resource center

NMTCB Nuclear Medicine Technology Review: Radiopharmaceutical preparation

Review radiopharmaceutical preparation for this NMTCB Nuclear Medicine Technology question with the key prompt clue, correct-answer reasoning, distractor checks, and sources to verify next.

Practice this exact exam Back to Resource Center

This question-specific review guide is tied to the answer reasoning for a PracticeTestVault item. Use it after you answer the question so the review stays focused on what the prompt actually tested.

What this question is testing

Objective: Radiopharmaceutical preparation

Prompt focus: During radiochemical purity testing of a technetium-99m radiopharmaceutical, the presence of free (unbound) technetium-99m pertechnetate is most likely to localize in which structures if administered?

Why the correct answer works

The thyroid, salivary glands, and stomach

Free technetium-99m pertechnetate localizes in the thyroid, salivary glands, and stomach.

Why the tempting wrong answer fails

Free pertechnetate does not specifically localize in the skeleton; that is the pattern of bone agents.

Plain-language takeaway

Free technetium-99m pertechnetate behaves like iodide and is taken up by the thyroid, salivary glands, and gastric mucosa. Detecting it confirms a radiochemical impurity in the preparation.

Simple analogy

Think of radiopharmaceutical preparation like following a short checklist: identify the clue, confirm the rule, and then make the move that fits this exact scenario.

How to review it before a retake

  • Underline the command word and name what the question is asking before rereading the choices.
  • Compare the correct answer against the closest distractor and write the exact detail that separates them.
  • Retest this objective with a fresh question without looking at the rationale first.

Sources to verify next